High resolution NMR spectroscopy, currently known as " metabolomics", is a technology enabling the rapid, noninvasive and low cost determination of low molecular weigh metabolites (e.g. aminoacids) in biological fluids such as plasma, urine, saliva, cerebrospinal fluid and others. According to Nicholson "Metabolomics is the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modification". Over the past 10 years this technology made it possible to discover of a number of lesser-known organ-specific metabolites that has been demonstrated to be reliable indicators of both organ function and viability. Consequently metabolomics has been used, with interesting results, for the functional evaluation of many organs (kidney, liver, heart), drug toxicity and post-transplant monitoring. The international literature demonstrates a growing interest for this technology and its capabilities.

Metabolomics and medical practice / Conti, Filippo; Manganaro, Mario; Miccheli, Alfredo. - In: LA CLINICA TERAPEUTICA. - ISSN 0009-9074. - STAMPA. - 157:6(2006), pp. 549-552.

Metabolomics and medical practice

CONTI, Filippo;MANGANARO, Mario;MICCHELI, Alfredo
2006

Abstract

High resolution NMR spectroscopy, currently known as " metabolomics", is a technology enabling the rapid, noninvasive and low cost determination of low molecular weigh metabolites (e.g. aminoacids) in biological fluids such as plasma, urine, saliva, cerebrospinal fluid and others. According to Nicholson "Metabolomics is the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modification". Over the past 10 years this technology made it possible to discover of a number of lesser-known organ-specific metabolites that has been demonstrated to be reliable indicators of both organ function and viability. Consequently metabolomics has been used, with interesting results, for the functional evaluation of many organs (kidney, liver, heart), drug toxicity and post-transplant monitoring. The international literature demonstrates a growing interest for this technology and its capabilities.
2006
Drugs; Heart; Kidney; Liver; Metabolomics; Transplants
01 Pubblicazione su rivista::01a Articolo in rivista
Metabolomics and medical practice / Conti, Filippo; Manganaro, Mario; Miccheli, Alfredo. - In: LA CLINICA TERAPEUTICA. - ISSN 0009-9074. - STAMPA. - 157:6(2006), pp. 549-552.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/8580
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 9
  • ???jsp.display-item.citation.isi??? ND
social impact